Healthcare provider profile · identity verified

Mona Perez, N.P.

Nurse Practitioner · NYACK, NY · NPI 1043546468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	800	397
Amlodipine Besylate	Amlodipine Besylate	433	228
Omeprazole	Omeprazole	333	134
Metformin Hcl	Metformin Hcl	314	162
Lisinopril	Lisinopril	290	150
Fluticasone Propionate	Fluticasone Propionate	288	113
Jardiance	Empagliflozin	255	98
Albuterol Sulfate Hfa	Albuterol Sulfate	243	81
Diclofenac Sodium	Diclofenac Sodium	237	90
Gabapentin	Gabapentin	237	87
Famotidine	Famotidine	230	103
Losartan Potassium	Losartan Potassium	223	112
Ammonium Lactate	Ammonium Lactate	213	65
Metoprolol Succinate	Metoprolol Succinate	200	92
Ozempic	Semaglutide	168	64
Eliquis	Apixaban	164	47
Carvedilol	Carvedilol	154	74
Levothyroxine Sodium	Levothyroxine Sodium	148	77
Hydrochlorothiazide	Hydrochlorothiazide	146	72
Tamsulosin Hcl	Tamsulosin Hcl	140	66
Alcohol Prep Pads	Alcohol Antiseptic Pads	136	51
Rosuvastatin Calcium	Rosuvastatin Calcium	135	72
Pantoprazole Sodium	Pantoprazole Sodium	125	59
Meclizine Hcl	Meclizine Hcl	114	54
Alendronate Sodium	Alendronate Sodium	100	39
Trulicity	Dulaglutide	94	44
Januvia	Sitagliptin Phosphate	90	38
Montelukast Sodium	Montelukast Sodium	87	39
Duloxetine Hcl	Duloxetine Hcl	78	29
Chlorthalidone	Chlorthalidone	75	36
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	74	31
Ketoconazole	Ketoconazole	67	27
Furosemide	Furosemide	66	31
Escitalopram Oxalate	Escitalopram Oxalate	65	32
Clotrimazole	Clotrimazole	64	18
Ibuprofen	Ibuprofen	60	30
Single Use Swab	Alcohol Antiseptic Pads	60	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	33
Simvastatin	Simvastatin	55	31
Nifedipine Er	Nifedipine	53	30
Rybelsus	Semaglutide	53	21
Vitamin D2	Ergocalciferol (Vitamin D2)	52	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	31
Xarelto	Rivaroxaban	50	21
Ezetimibe	Ezetimibe	48	30
Sertraline Hcl	Sertraline Hcl	47	17
Latanoprost	Latanoprost	45	15
Torsemide	Torsemide	45	20
Mirtazapine	Mirtazapine	44	21
Clopidogrel	Clopidogrel Bisulfate	43	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	21
Farxiga	Dapagliflozin Propanediol	42	19
Ventolin Hfa	Albuterol Sulfate	41	13
Glipizide Er	Glipizide	40	17
Metformin Hcl Er	Metformin Hcl	37	19
Novolog Flexpen	Insulin Aspart	37	16
Symbicort	Budesonide/Formoterol Fumarate	37	20
Allopurinol	Allopurinol	36	16
Donepezil Hcl	Donepezil Hcl	36	13
Finasteride	Finasteride	36	16
Pravastatin Sodium	Pravastatin Sodium	35	21
Advair Hfa	Fluticasone Propion/Salmeterol	34	15
Entresto	Sacubitril/Valsartan	34	15
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	33	suppressed
Lidocaine	Lidocaine	32	15
Spironolactone	Spironolactone	32	21
Triamcinolone Acetonide	Triamcinolone Acetonide	32	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	18
Naproxen	Naproxen	30	17
Azelastine Hcl	Azelastine Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	11
Incruse Ellipta	Umeclidinium Bromide	29	12
Baclofen	Baclofen	28	suppressed
Hydrocortisone	Hydrocortisone	28	15
Alcohol Pads	Alcohol Antiseptic Pads	27	suppressed
Meloxicam	Meloxicam	27	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	27	suppressed
Trazodone Hcl	Trazodone Hcl	26	15
Alcohol Swabs	Alcohol Antiseptic Pads	25	suppressed
Valsartan	Valsartan	25	11
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	11
Nitroglycerin	Nitroglycerin	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	11
Ciclopirox	Ciclopirox Olamine	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Nystatin	Nystatin	18	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	11
Restasis	Cyclosporine	17	suppressed
Glipizide	Glipizide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Atenolol	Atenolol	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Linzess	Linaclotide	15	suppressed
Topiramate	Topiramate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Methimazole	Methimazole	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	14	suppressed
Colchicine	Colchicine	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
True Comfort Pro Alcohol Pads	Alcohol Antiseptic Pads	12	suppressed
Eplerenone	Eplerenone	11	suppressed
Estradiol	Estradiol	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Nyamyc	Nystatin	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error